Acelyrin, RTW Venture Fund’s Portfolio Company, Raises $540 Million in IPO
LONDON, UK: RTW Venture Fund’s portfolio company, Acelyrin, Inc. announced the pricing of its initial public offering (IPO) and admission to trade on Nasdaq Global...
Apogee Therapeutics as completes $149 million Series B financing round
LONDON, UK: Apogee Therapeutics LLC has completed $149 million Series B financing round. RTW Venture Fund, alongside other investment vehicles of RTW Investments LP participated...